Pain Treatment Biotech Egalet Files for a $69 Million IPO
Published: Oct 17, 2013
Egalet, which is developing abuse-deterrent oral products for the treatment of pain, filed on Wednesday with the SEC to raise up to $69 million in an initial public offering. The Malvern, PA-based company, which was founded in 1995, plans to list on the NASDAQ under the symbol EGLT.
Help employers find you! Check out all the jobs and post your resume.